September 4th, 2013
New Dual Biomarker Test Could Speed Rule-Out of MI in the ED
Larry Husten, PHD
A new study suggests that patients with suspected ACS and negative troponin and copeptin results at admission can safely be discharged if the clinical assessment is consistent with that decision.
September 4th, 2013
Something New, or the Same Again?
Paddy Barrett, MB BCh BAO MRCPI MCTI
What’s the value of the ESC Congress, wonders this Fellow. More than the cutting-edge science, it’s the way the Congress strengthens the unity among all of us in the community of cardiovascular disease, both at home and abroad.
September 4th, 2013
Same Disease, Different Tools
Amanda Ruth Vest, MBBS
The standard pharmacological heart-failure treatment may not have changed much in the U.S. recently, but this fellow discovers different approaches in Europe and some potential new drugs on the horizon.
September 3rd, 2013
Echo CRT Trial – Going Narrow Doesn’t Broaden CRT Population
Edward J. Schloss, MD
A once promising indication for cardiac resynchronization therapy (CRT) in selected heart failure patients with narrow QRS intervals has suffered a major blow with the premature termination of the Biotronik sponsored multicenter EchoCRT trial.
September 3rd, 2013
Renal Denervation: The Next Magic Bullet?
M. Louis Handoko, MD PhD
Hypertension, diabetes, acute and chronic heart failure, worsening of renal function, obstructive sleep apnea…. A CardioExchange Fellow reacts to a session on new potential indications for this treatment modality.
September 3rd, 2013
Hearts and Minds
Paddy Barrett, MB BCh BAO MRCPI MCTI
What do cardiologists have yet to do to encourage the adoption of the best behavioral interventions?
September 3rd, 2013
A Transatlantic Taste
Amanda Ruth Vest, MBBS
A fellow wonders about worldwide differences in clinical and research approaches in cardiology, as she attends a session on a controversial area that sits uncomfortably alongside the weight-loss message central to American efforts to improve cardiovascular health.
September 3rd, 2013
Speedy Tour de France Racers Slower to Die
Larry Husten, PHD
For more of our ESC.13 coverage of late-breaking clinical trials, interviews with the authors of the most important research, and blogs from our fellows on the most interesting presentations at the meeting, check out our Coverage Headquarters. In recent years, concerns have been raised about possible adverse cardiovascular effects of intense endurance exercise. Additional concerns have […]
September 3rd, 2013
For CRT, Let ECG — Not Echo — Be Your Guide
Clyde Yancy, MD and John Ryan, MD
Clyde Yancy, coauthor of the NEJM editorial about the EchoCRT Study Group’s randomized trial of echocardiography-guided CRT, provides further insights about the findings.
September 3rd, 2013
Study Fails to Support Broader Patient Population for Cardiac-Resynchronization Therapy
Larry Husten, PHD
A new study from the Echo-CRT study group shows that CRT is not beneficial in patients with HF and a narrow QRS complex and may even be harmful.